Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomised Controlled Trial of the Effect of Magnesium Sulphate Administration on Red Cell Transketolase Activity in Alcohol Dependent Patients at Risk of Wernicke Korsakoff Syndrome Treated With Thiamine

NCT03466528 is registered in ClinicalTrials.gov with Glasgow Royal Infirmary as lead sponsor.

NCT NCT03466528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03466528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomised Controlled Trial of the Effect of Magnesium Sulphate Administration on Red Cell Transketolase Activity in Alcohol Dependent Patients at Risk of Wernicke Korsakoff Syndrome Treated With Thiamine
Lead sponsor
Glasgow Royal Infirmary
Phase
Phase 2/3
Overall status
Completed
Start date
December 16, 2016
Completion date
June 19, 2018
Enrollment
127 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol withdrawal, lactic acidosis, magnesium deficiency, vitamin b1 deficiency, wernicke encephalopathy